Related Experiment Video
Updated: Oct 4, 2025

Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
Published on: August 11, 2023
Association of neovascular age-related macular degeneration with migraine
Tung-Mei Kuang1,2,3, Sudha Xirasagar4, Yi-Wei Kao5,6
1Department of Ophthalmology, Taipei Veterans General Hospital, Taipei, Taiwan.
Abstract:
Patients with early onset vascular pathology have been reported to manifest neovascular age-related macular degeneration (AMD). While the blood vessels involved in pathogenesis of migraine remains controversial, it is generally accepted that a major contributor is blood vessel pathology. This study aimed to examine the association between migraine and AMD using a nationwide population-based dataset. Retrospective claims data were collected from the Taiwan National Health Insurance Research Database. We identified 20,333 patients diagnosed with neovascular AMD (cases), and we selected 81,332 propensity score-matched controls from the remaining beneficiaries in Taiwan's National Health Insurance system. We used Chi-square tests to explore differences in the prevalence of migraine prior to the index date between cases and controls. We performed multiple logistic regressions to estimate the odds of prior migraine among neovascular AMD patients vs. controls after adjusting for age, sex, monthly income, geographic location, residential urbanization level, hyperlipidemia, diabetes, coronary heart disease, hypertension, and previous cataract surgery. A total of 5184 of sample patients (5.1%) had a migraine claim before the index date; 1215 (6.1%) among cases and 3969 (4.9%) among controls (p < 0.001), with an unadjusted OR of 1.239 (95% CI 1.160~1.324, p < 0.001) for prior migraine among cases relative to controls. Furthermore, the adjusted OR was 1.201 (95% CI 1.123~1.284; p < 0.001) for AMD cases relative to controls. The study offers population-based evidence that persons with migraine have 20% higher risk of subsequently being diagnosed with neovascular AMD.
Insights
Migraine patients show a 20% increased risk of developing neovascular age-related macular degeneration (AMD). This population-based study links migraine history to a higher likelihood of AMD diagnosis, highlighting vascular connections.
Area of Science:
- Ophthalmology
- Neurology
- Epidemiology
Background:
- Neovascular age-related macular degeneration (AMD) is associated with early-onset vascular pathology.
- The role of blood vessel pathology in migraine pathogenesis is recognized, though controversial.
- Understanding the link between migraine and AMD is crucial for identifying shared vascular risk factors.
Purpose of the Study:
- To investigate the association between a history of migraine and the subsequent diagnosis of neovascular AMD.
- To determine if migraine is a risk factor for developing neovascular AMD using population-based data.
Main Methods:
- A retrospective cohort study using Taiwan's National Health Insurance Research Database.
- Identified 20,333 neovascular AMD patients (cases) and 81,332 propensity score-matched controls.
- Analyzed migraine prevalence before the index date using Chi-square tests and logistic regression, adjusting for multiple covariates.
Main Results:
- A higher prevalence of migraine was observed in neovascular AMD cases (6.1%) compared to controls (4.9%) (p < 0.001).
- Patients with migraine had an unadjusted odds ratio (OR) of 1.239 for developing neovascular AMD.
- Adjusted OR for prior migraine among neovascular AMD cases was 1.201 (p < 0.001), indicating a 20% increased risk.
Conclusions:
- This population-based study provides evidence linking migraine to an increased risk of neovascular AMD.
- Migraine may be a significant risk factor for the development of neovascular AMD.
- Further research into shared vascular mechanisms underlying migraine and AMD is warranted.
More Related Videos
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment

